Literature DB >> 25499917

Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.

Gianfranco Pasut1, Donatella Paolino2, Christian Celia3, Anna Mero1, Adrian Steve Joseph1, Joy Wolfram4, Donato Cosco2, Oddone Schiavon1, Haifa Shen5, Massimo Fresta6.   

Abstract

Pegylation of nanoparticles has been widely implemented in the field of drug delivery to prevent macrophage clearance and increase drug accumulation at a target site. However, the shielding effect of polyethylene glycol (PEG) is usually incomplete and transient, due to loss of nanoparticle integrity upon systemic injection. Here, we have synthesized unique PEG-dendron-phospholipid constructs that form super stealth liposomes (SSLs). A β-glutamic acid dendron anchor was used to attach a PEG chain to several distearoyl phosphoethanolamine lipids, thereby differing from conventional stealth liposomes where a PEG chain is attached to a single phospholipid. This composition was shown to increase liposomal stability, prolong the circulation half-life, improve the biodistribution profile and enhance the anticancer potency of a drug payload (doxorubicin hydrochloride).
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer therapy; Liposome; Pegylation; Phospholipid; Polyethylene glycol

Mesh:

Substances:

Year:  2014        PMID: 25499917     DOI: 10.1016/j.jconrel.2014.12.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  34 in total

1.  Contribution of Kupffer cells to liposome accumulation in the liver.

Authors:  Emma Samuelsson; Haifa Shen; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Colloids Surf B Biointerfaces       Date:  2017-07-15       Impact factor: 5.268

2.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

3.  Toward Hemocompatible Self-assembling Antimicrobial Nanofibers: Understanding the Synergistic Effect of Supramolecular Structure and PEGylation on Hemocompatibility.

Authors:  Dawei Xu; Qian Ran; Yang Xiang; Jiang Linhai; Britannia M Smith; Fadi Bou-Abdallah; Reidar Lund; Zhongjun Li; He Dong
Journal:  RSC Adv       Date:  2016-01-26       Impact factor: 3.361

Review 4.  Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles.

Authors:  Sara Busatto; Anthony Pham; Annie Suh; Shane Shapiro; Joy Wolfram
Journal:  Biomed Microdevices       Date:  2019-04-15       Impact factor: 2.838

5.  Steering the Clinical Translation of Delivery Systems for Drugs and Health Products.

Authors:  Rosario Pignatello; Pietro Matricardi
Journal:  Pharmaceutics       Date:  2020-04-13       Impact factor: 6.321

6.  Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.

Authors:  Leyuan Xu; W Andrew Yeudall; Hu Yang
Journal:  Acta Biomater       Date:  2017-04-22       Impact factor: 8.947

Review 7.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

8.  Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.

Authors:  Ofonime Udofot; Kevin Affram; Taylor Smith; Bulumko Tshabe; Sunil Krishnan; Mandip Sachdeva; Edward Agyare
Journal:  J Nat Sci       Date:  2016

Review 9.  Multistage vector (MSV) therapeutics.

Authors:  Joy Wolfram; Haifa Shen; Mauro Ferrari
Journal:  J Control Release       Date:  2015-08-08       Impact factor: 9.776

10.  Hesperetin Liposomes for Cancer Therapy.

Authors:  Joy Wolfram; Bronwyn Scott; Kathryn Boom; Jianliang Shen; Carlotta Borsoi; Krishna Suri; Rossella Grande; Massimo Fresta; Christian Celia; Yuliang Zhao; Haifa Shen; Mauro Ferrari
Journal:  Curr Drug Deliv       Date:  2016       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.